Beximco Pharma Regulatory News (BXP)

29 May 2007 13:36

Beximco Pharmaceuticals Ltd29 May 2007 29 May 2007 Beximco Pharma Commences Exports to Papua New Guinea Beximco Pharmaceuticals Ltd. ("BPL" or the "Company"), the leadingpharmaceutical manufacturer and the largest pharmaceutical exporter ofBangladesh today announces that is has started supplying its medicines to PapuaNew Guinea, one of the five LDCs of Oceania. Mr. Nazmul Hassan, CEO of Beximco Pharma said: "Commencing export to Papua New Guinea is a part of BPL's strategy to extendits presence in the LDCs. Papua New Guinea is the 7th LDC after Myanmar, Nepal,Bhutan, Cambodia, Rwanda and Somalia that BPL has successfully exported itsmedicines. By entering the Papua New Guinea market, we are confident that itwill further steer BPL's growth in the region." For further enquiries please contact: Beximco Pharma Tel: +880 2 861 9151, ext.2080Nazmul Hassan, CEO Financial Dynamics Tel: +44 (0)20 7269 7169John Gilbert Libertas Capital Tel: +44 (0)20 7569 9650Aamir Quraishi/Andrew Hardy About Beximco Pharmaceuticals Limited Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sellsgeneric pharmaceutical formulation products, active pharmaceutical ingredientsand intravenous fluids. The Company also manufactures and markets its ownbranded generics for almost all diseases. The Company also undertakes contractmanufacturing for multinational pharmaceutical companies. The Company operatesfrom a 20 acre site in Dhaka and currently employs over 2,300 staff. The Company's products are sold to retail outlets, medical institutions andother pharmaceutical manufacturers in Bangladesh, in regional markets such asPakistan, Nepal, Bhutan and Myanmar and in other markets overseas, principallyin East Africa and South East Asia, including Singapore. This information is provided by RNS The company news service from the London Stock Exchange